These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37413788)

  • 1. Nucleation During Storage Impeded Supersaturation in the Dissolution Process of Amorphous Celecoxib.
    Song J; Kawakami K
    Mol Pharm; 2023 Aug; 20(8):4050-4057. PubMed ID: 37413788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Crystal Nuclei on Dissolution of Amorphous Drugs.
    Yao X; Yu L; Zhang GGZ
    Mol Pharm; 2023 Mar; 20(3):1796-1805. PubMed ID: 36749110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage.
    Edueng K; Mahlin D; Gråsjö J; Nylander O; Thakrani M; Bergström CAS
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31357587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Cellulosic Polymer's Variables on Dissolution/Solubility of Amorphous Felodipine and Crystallization Inhibition from a Supersaturated State.
    Shi NQ; Jin Y; Zhang Y; Che XX; Xiao X; Cui GH; Chen YZ; Feng B; Li ZQ; Qi XR
    AAPS PharmSciTech; 2018 Dec; 20(1):12. PubMed ID: 30560388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization.
    Moseson DE; Corum ID; Lust A; Altman KJ; Hiew TN; Eren A; Nagy ZK; Taylor LS
    AAPS J; 2021 May; 23(4):69. PubMed ID: 34002256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
    Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
    Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Crystal Nucleation and Growth in Aqueous Drug Solutions: Impact of Different Polymers on the Supersaturation Profiles of Amorphous Drugs-The Case of Alpha-Mangostin.
    Budiman A; Citraloka ZG; Muchtaridi M; Sriwidodo S; Aulifa DL; Rusdin A
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
    Sarode AL; Wang P; Obara S; Worthen DR
    Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.
    Gupta P; Chawla G; Bansal AK
    Mol Pharm; 2004; 1(6):406-13. PubMed ID: 16028352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine.
    Zhao P; Hu G; Chen H; Li M; Wang Y; Sun N; Wang L; Xu Y; Xia J; Tian B; Liu Y; He Z; Fu Q
    Int J Pharm; 2022 Mar; 616():121538. PubMed ID: 35124119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelation Elimination and Crystallization Inhibition by Co-Amorphous Strategy for Amorphous Curcumin.
    Han J; Wei Y; Li L; Song Y; Pang Z; Qian S; Zhang J; Gao Y; Heng W
    J Pharm Sci; 2023 Jan; 112(1):182-194. PubMed ID: 35901945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib-Loaded Self-micellizing Solid Dispersion Suppresses Its Delayed Absorption in Rats with Impaired Gastrointestinal Motility.
    Ogino M; Yakushiji K; Suzuki H; Yamauchi Y; Seto Y; Sato H; Onoue S
    Chem Pharm Bull (Tokyo); 2023; 71(10):787-791. PubMed ID: 37779081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the behavior of amorphous pharmaceutical systems during dissolution.
    Alonzo DE; Zhang GG; Zhou D; Gao Y; Taylor LS
    Pharm Res; 2010 Apr; 27(4):608-18. PubMed ID: 20151181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
    J Pharm Sci; 2013 Jul; 102(7):2273-81. PubMed ID: 23658029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Devitrification of amorphous celecoxib.
    Gupta P; Bansal AK
    AAPS PharmSciTech; 2005 Sep; 6(2):E223-30. PubMed ID: 16353981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amorphous solid dispersions containing residual crystallinity: Influence of seed properties and polymer adsorption on dissolution performance.
    Moseson DE; Parker AS; Beaudoin SP; Taylor LS
    Eur J Pharm Sci; 2020 Apr; 146():105276. PubMed ID: 32092362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
    Ojo AT; Lee PI
    J Pharm Sci; 2021 Apr; 110(4):1495-1512. PubMed ID: 32818440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.